IOVA vs MSFT: Which Stock is Better?
Side-by-side comparison of Iovance Biotherapeutics Inc and Microsoft Corp in 2026
IOVA
Iovance Biotherapeutics Inc
$3.64
MSFT
Microsoft Corp
$387.00
Key Metrics Comparison
| Metric | IOVA | MSFT | Winner |
|---|---|---|---|
| Market Cap | $1.43B | N/A | IOVA |
| P/E Ratio | N/A | 24.04 | MSFT |
| EPS (TTM) | $N/A | $15.99 | MSFT |
| Revenue Growth | 0.2% | 0.2% | IOVA |
| Gross Margin | 34.3% | 68.6% | MSFT |
Analyze IOVA
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IOVA or MSFT a better investment?
Comparing IOVA and MSFT: Iovance Biotherapeutics Inc has a market cap of $1.43B while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IOVA and MSFT?
IOVA (Iovance Biotherapeutics Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IOVA or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IOVA or MSFT?
IOVA has higher revenue growth at 0.2% vs 0.2% for MSFT.
Which company is more profitable: IOVA or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.6% compared to 34.3% for IOVA.
Which is the larger company: IOVA or MSFT?
Iovance Biotherapeutics Inc (IOVA) is larger with a market cap of $1.43B compared to N/A for MSFT.
Should I buy IOVA or MSFT in 2026?
Both IOVA and MSFT have investment merit. IOVA trades at $3.64 while MSFT trades at $387.00. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IOVA and MSFT stock?
Key differences: Market Cap ($1.43B vs N/A), P/E Ratio (N/A vs 24.0x), Revenue Growth (0.2% vs 0.2%), Gross Margin (34.3% vs 68.6%).